DRG Fingertip insights

The HealthLeaders-InterStudy Market Analyst team analyzes major developments at the nation’s publicly held health plans each quarter through their financial releases and conference call transcripts. T…

The HealthLeaders-InterStudy Market Analyst team analyzes major developments at the nation’s publicly held health plans each quarter through their financial releases and conference call transcripts. T…

Health reform has spiked consumer interest in the individual insurance market California, but policyholders are finding shrinking benefits in the sector; in particular, plans with maternity coverage a…

Commercial markets in Colorado and Nevada have been shaken up by expansion of HMOs and, in the case of Las Vegas, new market entrants. At the same time, local brokers say employers are not likely to s…

The HealthLeaders-InterStudy Market Analyst team analyzes major developments at the nation’s publicly held health plans each quarter through their financial releases and conference call transcripts. T…

Uncertainty about the economy and the effects of health reform put a damper on the South's health insurance market. Commercial enrollment is essentially flat in Alabama, Georgia, Louisiana and Ten…

The HealthLeaders-InterStudy Market Analyst team analyzes major developments at the nation’s publicly held health plans each quarter through their financial releases and conference call transcripts. T…

The HealthLeaders-InterStudy Market Analyst team analyzes major developments at the nation’s publicly held health plans each quarter through their financial releases and conference call transcripts. T…

The HealthLeaders-InterStudy Market Analyst team analyzes major developments at the nation’s publicly held health plans each quarter through their financial releases and conference call transcripts. T…

Health plans in Massachsuetts, coming off one of their toughest years financially, are battling state regulators over premium increases, and the battle is hitting insurers' bottom lines. Maine is…

The HealthLeaders-InterStudy Market Analyst team analyzes major developments at the nation’s publicly held health plans each quarter through their financial releases and conference call transcripts. T…

While we forecast sales of oncology drugs in the United States to grow at a compound annual growth rate of 4.4% between now and 2016, we forecast sales of monoclonal antibodies (MAbs) in oncology to g…